Eric A. Rose's most recent trade in Orchestra BioMed Holdings Inc was a trade of 17,068 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 20, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Orchestra BioMed Holdings Inc | Eric A. Rose | Director | 20 Jun 2024 | 17,068 | 17,068 | - | - | Stock Option (Right to Buy) | ||
| Orchestra BioMed Holdings Inc | Eric A. Rose | Director | 20 Jun 2024 | 5,376 | 7,544 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") | ||
| Orchestra BioMed Holdings Inc | Eric A. Rose | Director | 20 Jul 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | ||
| Orchestra BioMed Holdings Inc | Eric A. Rose | Director | 17 May 2023 | 2,325 | 2,325 | - | 1.1 | 2,511 | Common Stock, par value $0.0001 per share ("Common Stock") | |
| Orchestra BioMed Holdings Inc | Eric A. Rose | Director | 17 May 2023 | 2,325 | 0 | - | - | Warrant (Right to Buy) | ||
| Orchestra BioMed Holdings Inc | Eric A. Rose | Director | 17 May 2023 | 157 | 2,168 | - | 16.0 | 2,518 | Common Stock | |
| Orchestra BioMed Holdings Inc | Eric A. Rose | Director | 26 Jan 2023 | 23,250 | 23,250 | - | - | Nonstatutory Stock Option (Right to Buy) | ||
| SIGA Technologies Inc | Eric A. Rose | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2021 | 15,000 | 1,068,593 (1%) | 0% | - | Common Stock, par value $.0001 per share | |
| SIGA Technologies Inc | Eric A. Rose | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2021 | 15,000 | 0 | - | - | Restricted Stock Units |